Safety and immunogenicity of a new formulation of an inactivated hepatitis A vaccine

By Dagan R.   Greenberg D.   Goldenbertg-Gehtman P.   Vidor E.   Briantais P.   Pinsk V.   Athias O.   Dumas R.  

Vaccine, Vol. 17, Iss. 15, 1999-04 ,pp. : 1919-1925

Elsevier

Access to resources Recommend Favorite

Good immunogenicity of GBM strain inactivated hepatitis A vaccine in healthy male adults

By Garin D.   Vidor E.   Wallon M.   Fanget B.   Brasseur P.   Delolme H.   Caron F.   Mojon M.   Gravey A.   Humbert G.   Flehmig B.   Peyron F.  

Vaccine, Vol. 13, Iss. 2, 1995-02 ,pp. : 220-224

Elsevier

Access to resources Recommend Favorite

Immunogenicity of an inactivated hepatitis A vaccine administered according to two different schedules and the interference of other ''travellers'' vaccines with the immune response

By Bienzle U.   Bock H.L.   Kruppenbacher J.P.   Hofmann F.   Vogel G.E.   Clemens R.  

Vaccine, Vol. 14, Iss. 6, 1996-04 ,pp. : 501-505

Elsevier

Access to resources Recommend Favorite

Safety, immunogenicity and antibody persistence of an inactivated hepatitis A vaccine in 4 to 15 year old children

By Castillo de Febres O.   Chacon de Petrola M.   Casanova de Escalona L.   Naveda O.   Naveda M.   Estopinan M.   Bordones G.   Zambrano B.   Garcia A.   Dumas R.  

Vaccine, Vol. 18, Iss. 7, 1999-11 ,pp. : 656-664

Elsevier

Access to resources Recommend Favorite

Immunogenicity and safety of a new inactivated hepatitis A vaccine: a clinical trial with comparison of administration route

By Fisch A.   Cadilhac P.   Vidor E.   Prazuck T.   Dublanchet A.   Lafaix C.  

Vaccine, Vol. 14, Iss. 12, 1996-08 ,pp. : 1132-1136

Elsevier

Access to resources Recommend Favorite